Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 41427-41428 [2013-16433]

Download as PDF TKELLEY on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 78, No. 132 / Wednesday, July 10, 2013 / Notices allows the participant (or its counsel or representative) to digitally sign documents and access the E-Submittal server for any proceeding in which it is participating; and (2) advise the Secretary that the participant will be submitting a request or petition for hearing (even in instances in which the participant, or its counsel or representative, already holds an NRCissued digital certificate). Based on this information, the Secretary will establish an electronic docket for the hearing in this proceeding if the Secretary has not already established an electronic docket. Information about applying for a digital ID certificate is available on the NRC’s public Web site at http:// www.nrc.gov/site-help/e-submittals/ apply-certificates.html. System requirements for accessing the E-Submittal server are detailed in the NRC’s ‘‘Guidance for Electronic Submission,’’ which is available on the NRC’s public Web site at http:// www.nrc.gov/site-help/ e-submittals.html. Participants may attempt to use other software not listed on the Web site, but should note that the NRC’s E-Filing system does not support unlisted software, and the NRC Meta System Help Desk will not be able to offer assistance in using unlisted software. If a participant is electronically submitting a document to the NRC in accordance with the E-Filing rule, the participant must file the document using the NRC’s online, Web-based submission form. In order to serve documents through the Electronic Information Exchange System, users will be required to install a Web browser plug-in from the NRC’s Web site. Further information on the Webbased submission form, including the installation of the Web browser plug-in, is available on the NRC’s public Web site at http://www.nrc.gov/site-help/ e-submittals.html. Once a participant has obtained a digital ID certificate and a docket has been created, the participant can then submit a request for a hearing or petition for leave to intervene. Submissions should be in Portable Document Format (PDF) in accordance with the NRC guidance available on the NRC’s public Web site at http://www. nrc.gov/site-help/e-submittals.html. A filing is considered complete at the time the documents are submitted through the NRC’s E-filing system. To be timely, an electronic filing must be submitted to the E-Filing system no later than 11:59 p.m. Eastern Time on the due date. Upon receipt of a transmission, the EFiling system time-stamps the document and sends the submitter an email notice VerDate Mar<15>2010 17:42 Jul 09, 2013 Jkt 229001 confirming receipt of the document. The E-Filing system also distributes an email notice that provides access to the document to the NRC’s Office of the General Counsel and any others who have advised the Office of the Secretary that they wish to participate in the proceeding, so that the filer need not serve the document on those participants separately. Therefore, applicants and other participants (or their counsel or representative) must apply for and receive a digital ID certificate before a hearing request/ petition to intervene is filed so that they may obtain access to the document via the E-Filing system. A person filing electronically using the NRC’s adjudicatory E-Filing system may seek assistance by contacting the NRC Meta System Help Desk through the ‘‘Contact Us’’ link located on the NRC Web site at http://www.nrc.gov/ site-help/e-submittals.html, by email to MSHD.Resource@nrc.gov, or by a tollfree call to 1–866–672–7640. The NRC Meta System Help Desk is available between 9 a.m. and 7 p.m., Eastern Time, Monday through Friday, excluding government holidays. Participants who believe that they have good cause for not submitting documents electronically must file an extension request, in accordance with 10 CFR 2.302(g), with their initial paper filing requesting authorization to continue to submit documents in paper format. Such filings must be submitted by (1) first class mail addressed to the Office of the Secretary of the Commission, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, Attention: Rulemaking and Adjudications Staff; or (2) courier, express mail, or expedited delivery service to the Office of the Secretary, Sixteenth Floor, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852, Attention: Rulemaking and Adjudications Staff. Participants filing a document in this manner are responsible for serving the document on all other participants. Copies shall be sent to the Director, Office of Enforcement and the Assistant General Counsel for Materials Litigation and Enforcement at the same address, the Regional Administrator, NRC Region II, Marquis One Tower, Suite 1200, 245 Peachtree Center Avenue NE., Atlanta, GA 30303, and to the Licensee, Duke Energy Carolinas, LLC, Oconee Nuclear Station, 7800 Rochester Highway, Seneca, SC 29672. Filing is considered complete by first-class mail as of the time of deposit in the mail, or by courier, express mail, or expedited delivery service upon depositing the document with the provider of the PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 41427 service. A presiding officer, having granted an exemption request from using E-Filing, may require a participant or party use E-Filing if the presiding officer subsequently determines that the reason for granting the exemption from use of E-Filing no longer exists. Documents submitted in adjudicatory proceedings will appear in NRC’s electronic hearing docket, which is available to the public at http:// ehd1.nrc.gov/ehd, unless excluded pursuant to an Order of the Commission, an Atomic Safety and Licensing Board, or the presiding officer. Participants are requested not to include personal privacy information, such as social security numbers, home addresses, or home phone numbers in their filings, unless an NRC regulation or other law requires submission of such information. With respect to copyrighted works, except for limited excerpts that serve the purpose of the adjudicatory filings and would constitute a Fair Use application, participants are requested not to include copyrighted materials in their submissions. If a person other than the licensee requests a hearing, that person shall set forth with particularity the manner in which his or her interest is adversely affected by this Order and shall address the criteria set forth in 10 CFR 2.309(d) and (f). In the absence of any request for hearing or written approval of an extension of time in which to request a hearing, the provisions specified in Section IV above shall be final 30 days from the date of this Order without further order or proceedings. If an extension of time for requesting a hearing has been approved, the provisions specified in Section IV shall be final when the extension expires if a hearing request has not been received. Dated this 1st day of July 2013. For the Nuclear Regulatory Commission. Roy Zimmerman, Director, Office of Enforcement. [FR Doc. 2013–16588 Filed 7–9–13; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on SUMMARY: E:\FR\FM\10JYN1.SGM 10JYN1 41428 Federal Register / Vol. 78, No. 132 / Wednesday, July 10, 2013 / Notices September 9–10, 2013. A sample of agenda items to be discussed during the public session includes: (1) An update on the 10 CFR Part 35 Rulemaking; (2) a discussion on the development of 10 CFR 35.1000 Guidance; (3) a discussion on the ACMUI reporting structure; (4) permanent implant brachytherapy guidance; (5) the Medical Events Subcommittee Report. The agenda is subject to change. The current agenda and any updates will be available at http://www.nrc.gov/reading-rm/doccollections/acmui/meetings/2013.html or by emailing Ms. Sophie Holiday at the CONTACT INFORMATION below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Closed Sessions: September 09, 2013, from 8:30 a.m. to 10:30 a.m. and September 10, 2013 from 8:30 a.m. to 10:30 a.m. The first session will be closed for ACMUI training. The second session will be closed so that ACMUI members can prepare for a Commission Briefing in October 2013. Date and Time for Open Sessions: September 09, 2013, from 10:30 a.m. to 5:00 p.m. and September 10, 2013, from 10:30 a.m. to 5:00 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, MD 20852. Public participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Holiday using the information below. The meeting will also be webcast live: video.nrc.gov. CONTACT INFORMATION: Sophie J. Holiday, email: sophie.holiday@nrc.gov, telephone: (301) 415–7865. TKELLEY on DSK3SPTVN1PROD with NOTICES Conduct of the Meeting Bruce R. Thomadsen, Ph.D., will chair the meeting. Dr. Thomadsen will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Holiday at the contact information listed above. All submittals must be received by September 2, 2013, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s Web site http://www.nrc.gov/reading- VerDate Mar<15>2010 17:42 Jul 09, 2013 Jkt 229001 rm/doc-collections/acmui/meetings/ 2013.html on or about October 22, 2013. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Holiday of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. Dated: July 1, 2013. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2013–16433 Filed 7–9–13; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [EA–12–193; NRC–2013–0142] In the Matter of Licensee Identified in Attachment 1 and All Other Persons Who Obtain Safeguards Information Described Herein; Order Imposing Requirements for the Protection of Certain Safeguards Information (Effective Immediately) I The Licensee, identified in Attachment 1 1 to this Order, holds a license issued in accordance with the Atomic Energy Act of 1954, as amended, (AEA) by the U.S. Nuclear Regulatory Commission (NRC or the Commission) or an Agreement State, authorizing it to possess, use, and transfer items containing radioactive material quantities of concern. The NRC intends to issue security Orders to this licensee in the near future. The Order will require compliance with specific Additional Security Measures to enhance the security for certain radioactive material quantities of concern. The Commission has determined that these documents will contain Safeguards Information, will not be released to the public, and must be protected from unauthorized disclosure. Therefore, the Commission is imposing the requirements, as set forth in Attachments 2 and 3 to this Order and in Order EA–12–194, so that the Licensee can receive these documents. This Order also imposes requirements for the protection of Safeguards Information in the hands of any person,2 1 Attachment 1 contains sensitive information and will not be released to the public. 2 Person means (1) any individual, corporation, partnership, firm, association, trust, estate, public or private institution, group, government agency other than the Commission or the U.S. Department PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 whether or not a licensee of the Commission, who produces, receives, or acquires Safeguards Information. II The Commission has broad statutory authority to protect and prohibit the unauthorized disclosure of Safeguards Information. Section 147 of the AEA grants the Commission explicit authority to ‘‘. . . issue such orders, as necessary to prohibit the unauthorized disclosure of safeguards information . . .’’ This authority extends to information concerning the security measures for the physical protection of special nuclear material, source material, and byproduct material. Licensees and all persons who produce, receive, or acquire Safeguards Information must ensure proper handling and protection of Safeguards Information to avoid unauthorized disclosure in accordance with the specific requirements for the protection of Safeguards Information contained in Attachments 2 and 3 to this Order. The Commission hereby provides notice that it intends to treat violations of the requirements contained in Attachments 2 and 3 to this Order applicable to the handling and unauthorized disclosure of Safeguards Information as serious breaches of adequate protection of the public health and safety and the common defense and security of the United States. Access to Safeguards Information is limited to those persons who have established the need-to-know the information, are considered to be trustworthy and reliable, and meet the requirements of Order EA–12–194. A need-to-know means a determination by a person having responsibility for protecting Safeguard Information that a proposed recipient’s access to Safeguards Information is necessary in the performance of official, contractual, or licensee duties of employment. The Licensee and all other persons who obtain Safeguards Information must ensure that they develop, maintain and implement strict policies and procedures for the proper handling of Safeguards Information to prevent unauthorized disclosure, in accordance with the requirements in Attachments 2 and 3 to this Order. The Licensee must ensure that all contractors whose of Energy, except that the DOE shall be considered a person with respect to those facilities of the DOE specified in section 202 of the Energy Reorganization Act of 1974 (88 Stat. 1244), any State or any political subdivision of, or any political entity within a State, any foreign government or nation or any political subdivision of any such government or nation, or other entity; and (2) any legal successor, representative, agent, or agency of the foregoing. E:\FR\FM\10JYN1.SGM 10JYN1

Agencies

[Federal Register Volume 78, Number 132 (Wednesday, July 10, 2013)]
[Notices]
[Pages 41427-41428]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16433]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on

[[Page 41428]]

September 9-10, 2013. A sample of agenda items to be discussed during 
the public session includes: (1) An update on the 10 CFR Part 35 
Rulemaking; (2) a discussion on the development of 10 CFR 35.1000 
Guidance; (3) a discussion on the ACMUI reporting structure; (4) 
permanent implant brachytherapy guidance; (5) the Medical Events 
Subcommittee Report. The agenda is subject to change. The current 
agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2013.html or by emailing Ms. Sophie 
Holiday at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Sessions: September 09, 2013, from 8:30 
a.m. to 10:30 a.m. and September 10, 2013 from 8:30 a.m. to 10:30 a.m. 
The first session will be closed for ACMUI training. The second session 
will be closed so that ACMUI members can prepare for a Commission 
Briefing in October 2013.
    Date and Time for Open Sessions: September 09, 2013, from 10:30 
a.m. to 5:00 p.m. and September 10, 2013, from 10:30 a.m. to 5:00 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, MD 20852.
    Public participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
live: video.nrc.gov.

CONTACT INFORMATION: Sophie J. Holiday, email: sophie.holiday@nrc.gov, 
telephone: (301) 415-7865.

Conduct of the Meeting

    Bruce R. Thomadsen, Ph.D., will chair the meeting. Dr. Thomadsen 
will conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by September 2, 2013, and must pertain 
to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2013.html on or about October 22, 2013.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: July 1, 2013.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2013-16433 Filed 7-9-13; 8:45 am]
BILLING CODE 7590-01-P